BioCentury | Oct 24, 2020
Finance
Oct. 23 Quick Takes: RA Capital’s $461M new fund; plus venture rounds for Sirnaomics, 3D Medicines, Zhaoke, Orbus, Araris
...STP705 in Phase II testing for non-melanoma skin cancer and hypertrophic scar reduction. Sangel Capital, Longmen Capital...
